QIAGEN Net Income 2006-2021 | QGEN

QIAGEN annual/quarterly net income history and growth rate from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • QIAGEN net income for the quarter ending September 30, 2021 was $0.133B, a 687.34% increase year-over-year.
  • QIAGEN net income for the twelve months ending September 30, 2021 was $0.596B, a 211.38% increase year-over-year.
  • QIAGEN annual net income for 2020 was $0.359B, a 966.45% decline from 2019.
  • QIAGEN annual net income for 2019 was $-0.041B, a 121.77% decline from 2018.
  • QIAGEN annual net income for 2018 was $0.19B, a 371.31% increase from 2017.
QIAGEN Annual Net Income
(Millions of US $)
2020 $359
2019 $-41
2018 $190
2017 $40
2016 $80
2015 $130
2014 $116
2013 $69
2012 $130
2011 $96
2010 $144
2009 $138
2008 $89
2007 $50
2006 $71
2005 $62
QIAGEN Quarterly Net Income
(Millions of US $)
2021-09-30 $133
2021-06-30 $121
2021-03-31 $129
2020-12-31 $213
2020-09-30 $17
2020-06-30 $90
2020-03-31 $40
2019-12-31 $45
2019-09-30 $-161
2019-06-30 $45
2019-03-31 $30
2018-12-31 $61
2018-09-30 $60
2018-06-30 $37
2018-03-31 $32
2017-12-31 $-40
2017-09-30 $48
2017-06-30 $14
2017-03-31 $18
2016-12-31 $9
2016-09-30 $35
2016-06-30 $21
2016-03-31 $16
2015-12-31 $52
2015-09-30 $34
2015-06-30 $25
2015-03-31 $19
2014-12-31 $26
2014-09-30 $35
2014-06-30 $33
2014-03-31 $23
2013-12-31 $60
2013-09-30 $41
2013-06-30 $-52
2013-03-31 $20
2012-12-31 $38
2012-09-30 $29
2012-06-30 $33
2012-03-31 $29
2011-12-31 $-0
2011-09-30 $35
2011-06-30 $33
2011-03-31 $28
2010-12-31 $36
2010-09-30 $36
2010-06-30 $39
2010-03-31 $33
2009-12-31 $44
2009-09-30 $38
2009-06-30 $31
2009-03-31 $25
2008-12-31 $25
2008-09-30 $21
2008-06-30 $23
2008-03-31 $20
2007-12-31 $15
2007-09-30 $-7
2007-06-30 $23
2007-03-31 $20
2006-12-31 $19
2006-09-30 $19
2006-06-30 $14
2006-03-31 $18
2005-12-31 $17
2005-09-30 $18
2005-06-30 $14
2005-03-31 $14
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.357B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $125.010B 7.90
Bio-Rad Laboratories (BIO.B) United States $22.443B 45.55
Biohaven Pharmaceutical Holding (BHVN) United States $6.783B 0.00
Arcus Biosciences (RCUS) United States $3.105B 0.00
Emergent Biosolutions (EBS) United States $2.254B 8.10
ADC Therapeutics SA (ADCT) Switzerland $1.478B 0.00
Myovant Sciences (MYOV) United Kingdom $1.368B 0.00
Zymeworks (ZYME) Canada $0.861B 0.00
Ambrx Biopharma (AMAM) United States $0.337B 0.00
SQZ Biotechnologies (SQZ) United States $0.319B 0.00
Enzo Biochem (ENZ) United States $0.162B 15.90